Chemomab Therapeutics (CMMB) Net Income Growth (5y) (2022 - 2025)
Chemomab Therapeutics (CMMB) Net Income Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 714.32 Mn | 703.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 895.99% |
| Sep 30, 2025 | 22.08% |
| Dec 31, 2024 | 468.64% |
| Sep 30, 2024 | 17.28% |
| Jun 30, 2024 | 14.94% |
| Mar 31, 2024 | -26.83% |
| Dec 31, 2023 | 31.21% |
| Sep 30, 2023 | -70.13% |
| Jun 30, 2023 | 8.32% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 33.47% |